Sharecare to Participate in 41st Annual Canaccord Genuity Growth Conference

Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced that Jeff Arnold, co-founder, chairman and CEO, and Justin Ferrero, president and CFO, will participate in the 41st Annual Canaccord Genuity Growth Conference, including a presentation on Thursday, August 12, 2021 at 11:30 a.m. E.T. The webcast link will be available online at https://investors.sharecare.com/news-and-events/events-and-presentations.

About Sharecare

Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.

Media Relations:

Jen Martin Hall

jen@sharecare.com

Investor Relations:

Bob East

SharecareIR@westwicke.com

Total
0
Shares
Leave a Reply
Related Posts
Read More

Scripta Insights Co-founder & Chief Medical Officer Paul S. Bradley, MD, at Forefront of Medical Advancement, Doses First Patient in Moderna’s U.S. Phase 3 COVID-19 Vaccine Clinical Trial

This morning, Dr. Paul Bradley, co-founder and Chief Medical Officer of Scripta Insights, partner at BCG Medical Group, and Principal Investigator at Meridian Clinical Research's internal medicine site in Savannah, Ga., dosed the very first patient in the nation's first Phase 3 COVID-19 vaccine clinical trial. The trial is expected to enroll 30,000 adults to test the efficacy of a coronavirus vaccine developed by drugmaker Moderna.
Read More

Sagepath Joins the Reply Network

Sagepath has been renamed Sagepath Reply following the acquisition by REPLY [MTA, STAR: REY]. Reply has strengthened its presence in the North American market with its investment in Sagepath (www.sagepath.com), a leading U.S.-based marketing and technology company that specializes in Digital Transformation, Ecommerce and Digital Experience.